I'm "Commissioner methoxime"
Release time:
2020-08-14
I am "Commissioner methoxime"
"Wang Jie, please help me check the inventory of various specifications of cefmenoxime hydrochloride for injection this week." Every day at work, agent sales manager Zhang Xiaoyang asked me with her sweet voice.
Due to work needs, I was transferred from Jianfeng Sales Company to the former Jiangnan Pharmaceutical Factory in 2007 to engage in various trivial work of cefmenoxime hydrochloride for injection. It is exactly ten years now, and my colleagues also affectionately call me "Commissioner medoxime".
I vaguely remember that when 7# took over the work of cefmenoxime for injection in April, the sales volume in that month was about 22 g, 8 28 g, and by 9 and 10 , it had reached about 50 g, the whole sales volume of methyl oxime is "sesame blooming steadily high", and the situation is very gratifying.
In order to meet the needs of the sales department, the powder needle workshop worked hard to work overtime. The logistics personnel (including the leaders of the factory department) were not idle. In addition to doing their job well, as long as they had free time, they had to go to the workshop to help with packaging. Everyone said they were tired and happy. With the continuous improvement of Cefmenoxime hydrochloride for injection technology, the emergence of micronized Cefmenoxime hydrochloride for injection has pushed the sales volume to a new climax. I look at the climbing sales and am proud of my job.
As the Cefmenoxime Hydrochloride Commissioner for Injection, my daily work flow is to receive the delivery application form from the agent in the morning, issue an invoice to the Finance Department with the voucher, and hand it over to the warehouse keeper in the afternoon to tally the goods. The warehouse keeper and the warehouse keeper should carefully check whether the outer package of each piece of Cefmenoxime is complete, convenient transportation department delivery. After the goods are delivered, check the batch number and inventory of each specification of methyl oxime with the agent every day. Register the daily delivery quantity, then fax it to the finance department to issue VAT invoices, arrange the tax receipts and mail them to the agent. Occasionally, when there is a return, carefully make records and then hand them over to the warehouse return clerk for processing.
Simple things have been repeated for ten years. I witnessed and participated in the period when cefmenoxime hydrochloride for injection gradually grew from initial growth to prosperity. (Wang Meiqin)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page